APLM
Apollomics Inc.
NASDAQ · Healthcare · Biotechnology · US
$23.42
+3.97%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -21.41x
- Price / sales
- 8.03x
- Price / cash flow
- -6.58x
Enterprise value
- Enterprise value
- $65.6M
- EV / sales
- 7.72x
- EV / EBITDA
- -6.93x
- EV / EBIT
- -6.93x
- Market cap
- $68.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025